Oliver Donnelly
Papers
1
Total Citations
1
H-Index
1
About
Dr. Oliver Donnelly is a leading head and neck surgical oncologist whose research focuses on optimizing treatment for HPV-related oropharyngeal cancer. His major contributions center on comparing oncological and functional outcomes between transoral robotic surgery (TORS) and primary radiotherapy for early-stage p16-positive disease. In his seminal 2025 study, Dr. Donnelly analyzed T1-2 N0-1 patients, demonstrating that TORS with neck dissection—with or without adjuvant therapy—achieves comparable disease control while potentially preserving swallowing function and reducing long-term toxicity. This work directly informs the ongoing debate between surgical and non-surgical paradigms, offering critical data for personalized treatment decisions. With his research accumulating citations and shaping clinical guidelines, Dr. Donnelly is recognized for advancing minimally invasive approaches that balance cure with quality of life. His findings are particularly impactful for young, otherwise healthy patients with HPV-positive tumors, where survivorship outcomes matter most.
Research Focus
Key Achievements
Top Papers
- 1